Search Results - "Filshie, Robin J."

Ultra-low dose external beam radiotherapy for presumed choroidal lymphoma: a case report by Flanagan, Jeremy P. M., Ng, Michael, Kibrom, Awet Z., Filshie, Robin J. A., Stawell, Richard J., O’Day, Roderick F.

“…Primary choroidal lymphoma is a rare, slowly progressive intraocular malignancy. Most are low grade B cell lymphomas, often involving tissues adjacent to the…”
Get full text

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study by Ross, David M., Branford, Susan, Seymour, John F., Schwarer, Anthony P., Arthur, Christopher, Yeung, David T., Dang, Phuong, Goyne, Jarrad M., Slader, Cassandra, Filshie, Robin J., Mills, Anthony K., Melo, Junia V., White, Deborah L., Grigg, Andrew P., Hughes, Timothy P.

“…Most patients with chronic myeloid leukemia (CML) treated with imatinib will relapse if treatment is withdrawn. We conducted a prospective clinical trial of…”
Get full text

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells by Ross, David M., Pagani, Ilaria S., Shanmuganathan, Naranie, Kok, Chung H., Seymour, John F., Mills, Anthony K., Filshie, Robin J., Arthur, Christopher K., Dang, Phuong, Saunders, Verity A., Braley, Jodi, Yong, Agnes S., Yeung, David T., White, Deborah L., Grigg, Andrew P., Schwarer, Anthony P., Branford, Susan, Hughes, Timothy P.

“…Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs), approximately half of patients with chronic myeloid leukemia (CML)…”
Get full text

Detection of Novel Occult Germline Multi-Exon Deletions in Patients with DDX41 Familial Predisposition to Myeloid Malignancy by Maierhofer, Anna, Fox, Lucy C, Hutter, Stephan, Baer, Constance, Thompson, Ella, Nguyen, Tamia, Den Elzen, Nicole, Filshie, Robin J, Tiong, Ing S, Nadarajah, Niroshan, Meggendorfer, Manja, Kern, Wolfgang, Haferlach, Claudia, Haferlach, Torsten, Blombery, Piers

Get full text

Longitudinal Genomic Characterization Using Cell-Free DNA in Patients with Idiopathic Aplastic Anemia by Ryland, Georgina L, Fox, Lucy C, Chen, Xiangting, Yerneni, Satwica, Szer, Jeffrey, Bajel, Ashish, Filshie, Robin J, Morgan, Sue, Dawson, Sarah-Jane, Blombery, Piers

“…The molecular profile of clonal hematopoiesis in patients (pts) with idiopathic aplastic anaemia (iAA) has been shown to predict response to immunosuppressive…”
Get full text

Efficacy of Ibrutinib, Rituximab and Mini-CHOP in Very Elderly Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma: Primary Analysis of the Australasian Leukaemia & Lymphoma Group NHL29 Study by Verner, Emma, Johnston, Amanda, Pati, Nalini, Hawkes, Eliza, Lee, Hui-Peng, Cochrane, Tara, Cheah, Chan-Yoon, Filshie, Robin J, Purtill, Duncan, Sia, Hanlon, Enjeti, Anoop Kumar, Brown, Christina, Murphy, Nicholas E., Curnow, Jennifer, Lee, Kenneth, Walia, Mannu, Butcher, Belinda, Trotman, Judith

“…Introduction R-mini-CHOP is an established standard of care in elderly patients with DLBCL, with a 2yr OS of 59% and PFS of 47% (Peyrade et al, Lancet Oncol…”
Get full text

Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib by Quach, Hang, Nguyen, Khue Minh, Ku, Matthew, Bazargan, Ali, Filshie, Robin J, Tam, Constantine S., Demosthenous, Lisa Catherine, Prior, David

“…Background Carfilzomib (K), a second generation proteasome inhibitor that is approved for patients (pts) with relapsed refractory multiple myeloma (RRMM) is…”
Get full text

Early and Deep Molecular Responses Achieved with Frontline Asciminib in Chronic Phase CML - Interim Results from ALLG CML13 Ascend-CML by Yeung, David T, Shanmuganathan, Naranie, Reynolds, John, Branford, Susan, Walia, Mannu, Yong, Agnes S.M., Shortt, Jake, Burbury, Kate, Viiala, Nicholas, Cunningham, Ilona, Ross, David M., Harrup, Rosemary, Wright, Matthew, Forsyth, Cecily, D'Souza, Alwyn Bernard, Filshie, Robin J, Browett, Peter J., Lane, Steven W, Grove, Carolyn, Grigg, Andrew, Hughes, Timothy

Get full text

Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naïve and Relapsed/Refractory Severe Aplastic Anaemia - the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials by McQuilten, Zoe, Fox, Lucy C, Fox, Vanessa, Heritier, Stephane, Batt, Tracey J, Blombery, Piers, Curnow, Jennifer, Higgins, Alisa, Hiwase, Devendra, Filshie, Robin J, Firkin, Frank, Lacaze, Paul, Mason, Kylie D, Mills, Tony, Patil, Sushrut S., Pepperell, Dominic, Stevenson, William S, Szer, Jeffrey, Waters, Neil, Wilson, Kate, Ting, Stephen B, Wood, Erica M.

Get full text

Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome by Zeidan, Amer M., Borate, Uma, Pollyea, Daniel A., Brunner, Andrew M., Roncolato, Fernando, Garcia, Jacqueline S., Filshie, Robin J, Odenike, Olatoyosi, Watson, Anne-Marie, Krishnadasan, Ravi, Bajel, Ashish, Naqvi, Kiran, Zha, Jiuhong, Hogdal, Leah, Zhou, Ying, Hoffman, David, Kye, Steve, Garcia-Manero, Guillermo

“…▪ Introduction Patients (pts) with relapsed/refractory (R/R) higher-risk myelodysplastic syndromes (MDS) have a dismal median overall survival (OS) of 4.3 -…”
Get full text

Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study by McCaughan, Georgia J, Tran, Steven, Durrant, Simon, Harrison, Simon J, Morton, James, Horvath, Noemi, Spencer, Andrew, Kerridge, Ian H., Er, Jeremy An Ke, Barge, Luani, Bryant, Adam, Filshie, Robin J, Choong, Emily, Lai, Hock Choong, Tiley, Campbell, Mills, Anthony K, Butler, Andrew, Moore, John, Hertzberg, Mark, Kennedy, Glen A, Ho, P. Joy, Sidiqi, M Hasib, Bashford, John, Routledge, David, Taylor, Kerry, Lee, Cindy H., Kalff, Anna, Xia, Wei, Hamad, Nada

“…Background: Upfront autologous stem cell transplantation (ASCT) in multiple myeloma (MM) following induction therapy has been demonstrated to improve…”
Get full text

Long-Term Follow-up of the ALLG CML8 Twister Study of Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia (CML) by Ross, David M, Pagani, Ilaria S, Shanmuganathan, Naranie, Seymour, John F, Mills, Anthony K, Filshie, Robin J, Arthur, Christopher K, Dang, Phuong, Saunders, Verity A, Braley, Jody, Yeung, David T, White, Deborah L, Grigg, Andrew P, Schwarer, Anthony P, Branford, Susan, Hughes, Timothy P.

“…Introduction: Most patients (pts) with chronic phase CML treated with tyrosine kinase inhibitors (TKIs) can expect a near-normal life-expectancy, but…”
Get full text

Cytokines in haemopoietic progenitor mobilisation for peripheral blood stem cell transplantation by Filshie, Robin J A

“…Haemopoietic progenitors mobilised into peripheral blood are now almost universally used in autologous haemopoietic stem cell transplantation in the treatment…”
Get more information